Lupin receives USFDA approval for sodium sulfate/potassium sulfate and magnesium sulfate

Lupin Ltd has received final USFDA approval to market sodium sulfate, potassium sulfate, magnesium sulfate oral solution used in colonoscopy.
The company will market sodium sulfate, potassium sulfate, magnesium sulfate oral solution, 17.5 g/3.13 g/ 1.6 g per ounces as generic version of Braintree Laboratories. The approved product is indicated for cleansing of the colon in preparation of colonoscopy in adults. Suprep Bowel Prep Kit had US sales of USD 207.2 million.

Company Profile : Lupin Ltd

Be the first to comment

Leave a Reply

Your email address will not be published.


*